DISCLAIMER: This advertisement is not for legal services related to an incident that occurred in California or that a California court would have jurisdiction over.
Your CounselConnect
Pharmaceutical — active

Ozempic / GLP-1 Injury

Claims involving severe gastrointestinal injuries linked to Ozempic and similar GLP-1 drugs.

Check Eligibility — FreeFree Case Review

Symptoms & Injuries

  • Gastroparesis
  • Bowel obstruction
  • Persistent vomiting
  • Hospitalization

Eligibility Criteria

  • Used Ozempic, Wegovy, or Mounjaro
  • Severe GI injury requiring treatment

Hospitalization for gastroparesis, bowel obstruction, or related GI injury.

Timeline

1

Case Evaluation

Free review of your claim by participating attorneys.

2

Investigation

Gathering medical records, usage history, and damages documentation.

3

Filing / MDL

Claims may proceed individually or through consolidated MDL proceedings.

4

Discovery & Negotiation

Evidence exchange and potential settlement discussions.

MDL Information

GLP-1 RA MDL (MDL No. 3094) — In re: Glucagon-Like Peptide-1 Receptor Agonists Products Liability Litigation.

FAQ

Free Case Evaluation

See if you may qualify. No fees unless you win with a participating attorney.

Start Free Review

Legal Disclaimer

  • • DISCLAIMER: This advertisement is not for legal services related to an incident that occurred in California or that a California court would have jurisdiction over.
  • • Submitting a form does not guarantee representation, case acceptance, or financial compensation.